GARDASIL

Date	18 April 2007
Pharmaceutical formulation	GARDASIL, suspension for injection, Human Papillomavirus [types 6, 11, 16, 18] vaccine (recombinant, adsorbed) – vial (glass) – 0.5 ml Pack of 1 vial (CIP 377 143-6) GARDASIL, suspension for injection in prefilled syringe, Human Papillomavirus [types 6, 11, 16, 18] vaccine (recombinant, adsorbed) prefilled syringe (glass) – 0.5 ml Pack of 1 prefilled syringe + 2 needles (CIP 377 130-1) GARDASIL, suspension for injection in prefilled syringe, Human Papillomavirus [types 6, 11, 16, 18] vaccine (recombinant, adsorbed) prefilled syringe (glass) – 0.5 ml Pack of 1 prefilled syringe with needle guard device + 2 needles (CIP 377 133-0) GARDASIL, suspension for injection in prefilled syringe, Human Papillomavirus [types 6, 11, 16, 18] vaccine (recombinant, adsorbed) prefilled syringe (glass) – 0.5 ml Pack of 10 prefilled syringes with needle guard device + 20 needles (CIP 570 100-3)
ATC code	J07BM01
Active ingredient	Human Papillomavirus type 6 L1 Protein Human Papillomavirus type 11 L1 Protein Human Papillomavirus type 16 L1 Protein Human Papillomavirus type 18 L1 Protein
Laboratory / Manufacturer	SANOFI PASTEUR MSD
Reason for request	Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals (pack of 1) and inclusion on the list of medicines approved for use by hospitals (pack of 10)

Documents